DECIDE, or “Diagnostic Enhancement of Confidence by an International Distributed Environment”, brought together 13 partners from five European countries to develop and launch an e-service that allows the early diagnosis of Alzheimer’s and other neurodegenerative diseases.
The DECIDE platform examines new MRI / PET scan images, compares them to existing MRI images from a central database and extracts AD biomarkers. In simpler terms, DECIDE enables a physician at any remote hospital to analyse an MRI or a Positron Emission Tomography (PET) scan in a few minutes, whereas the same task on a single computer might take weeks or months.
DECIDE ran from 2010-2013, funded by the European Commission within the 7th Framework Programme (FP7).
Last Updated: Thursday 13 November 2014